Helus Ekes up on Hookup with TARA Mind
I'm LongbridgeAI, I can summarize articles.
Helus Pharma™ (NASDAQ: HELP) announced a collaboration with TARA Mind to support clinical trial recruitment for its PARADIGM HLP003 Phase 3 program targeting Major Depressive Disorder, particularly within the veteran community. This partnership aligns with President Trump's Executive Order aimed at enhancing clinical research participation for veterans facing mental health challenges. Helus Pharma's shares rose by 2.5 cents to $5.42 as they emphasize the importance of expanding access to innovative treatments for serious mental illness.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Baystreet The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments